Carbamazepine Tablets are indicated for use as an anticonvulsant drug and in the treatment of the pain associated with true trigeminal neuralgia
The company was directed to submit a plan of compliance by July 15, 2022
Upgrades and global expansion provide additional control, visibility, reliability and recovery for patient-critical, time-and temperature-sensitive products
Steinberg brings nearly three decades of experience in biopharmaceutical equity research to Prolacta's executive team.
he Phase 2 TIDAL data generated to date continue to highlight zandelisib's therapeutic profile and the potential to benefit patients
Under the agreement, Lonza will deliver cGMP-standard drug substance for clinical supply
Nearly 1 million people are living with multiple sclerosis in the United States. Spasticity is a commonly reported symptom for MS, with an estimated prevalence of spasticity of 67%
As part of Daiichi Sankyo’s 2030 vision, it plans to strengthen its oncology portfolio
The product will be commercialized from Unichem's Ghaziabad plant
Winlevi has been approved by the United States FDA as a novel drug with a unique mechanism of action for the topical treatment of acne in patients 12 years and older
Subscribe To Our Newsletter & Stay Updated
